Today's News |
BC Advantage Funds Announces Change to Its Board of Directors - Adds Heavy Hitter Director
Monday, February 2, 2015
Vancouver, BC, February 2, 2015--(T-Net)--B.C. Advantage Funds (VCC) Ltd. announced that Dr. Avtar Dhillon will step down from its Board of Directors, effective January 31, 2015, and be replaced by Mr. Don Enns.
Don is a well-known and respected member of the British Columbia technology community, having previously served as President of LifeSciences BC, the Province's life sciences industry association, and as President & CEO of CANTEST Ltd. which was sold in 2009 to Maxxam Analytics.
He currently serves as President & CEO of Northern Lipids Inc., a contract research and manufacturing organization servicing the biotechnology and pharmaceutical industries, and is Co-Chairman of the Life Sciences Advisory Panel of the National Research Council of Canada.
Frank Holler, Chairman & CEO of Advantage, said "I wish to welcome Don Enns to our Board of Directors and sincerely thank Dr. Avtar Dhillon for his substantial contribution over the years to Advantage. Avtar has been an active and long standing member of our Board and we wish him well with his future business activities."
About Advantage
B.C. Advantage Funds (VCC) Ltd. is a venture capital corporation, formed under the Small Business Venture Capital Act (British Columbia), to invest in emerging technology companies in the Province. For more information about Advantage, please visit our website at www.bcadvantagefunds.com.